Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 36,539 |
|
|||||
| News | - | ||||||
| Day High | 6.1519 | Low High |
|||||
| Day Low | 5.72 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Palisade Bio Inc | PALI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.1981 | -3.12% | 6.1519 | 12:04:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.10 | 5.72 | 6.1519 | 6.35 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 425 | 36,539 | $ 5.99 | $ 218,937 | - | 3.82 - 36.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:04:58 | 1 | $ 6.1608 | USD |
Palisade Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 18.44M | 12.13M | - | 250k | -12.3M | -1.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Palisade Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PALI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.05 | 8.17 | 4.50 | 5.91 | 4,863,224 | 0.1019 | 1.68% |
| 1 Month | 5.9295 | 9.65 | 3.82 | 5.92 | 2,995,887 | 0.2224 | 3.75% |
| 3 Months | 9.15 | 9.65 | 3.82 | 6.03 | 1,159,041 | -3.00 | -32.77% |
| 6 Months | 8.85 | 22.35 | 3.82 | 11.31 | 1,840,784 | -2.70 | -30.49% |
| 1 Year | 23.70 | 36.60 | 3.82 | 15.76 | 1,755,970 | -17.55 | -74.04% |
| 3 Years | 6,750.00 | 8,182.50 | 3.82 | 356.60 | 1,953,499 | -6,743.85 | -99.91% |
| 5 Years | 6,750.00 | 8,182.50 | 3.82 | 356.60 | 1,953,499 | -6,743.85 | -99.91% |
Palisade Bio Description
| Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. |
